Skip to main content
Clinical Trials/IRCT20170513033941N69
IRCT20170513033941N69RecruitingPhase 3

Comparing the effects of N-acetylcysteine administration and placebo on clinical status and metabolic profiles in overweight or obese women with fibrocystic changes of breast

Kashan University of Medical Sciences0 sites74 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
74

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 45 years (—)
Sex
Female

Inclusion Criteria

  • Patients aged 18-45 years
  • women diagnosed with fibrocystic breast disease
  • having moderate or severe cyclic mastalgia

Exclusion Criteria

  • Malignant breast diseases
  • Taking medicines for reducing pain (such as danazol, tamoxifen, bromocriptine) over the past three months
  • Menopause women
  • Pregnant or breastfeeding women
  • Psychological diseases
  • Unwillingness to cooperate

Investigators

Similar Trials

Effects of N-acetylcysteine administration... | Clinical Trial